Altium Capital Management LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001746382
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q1 2025 · 23 positions · Total reported value $39.48M · Top-10 concentration 88.3% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 20.0% · 1 new · 3 cut · 0 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -5.1% · vs SPY -7.3% · Prev Value $47.47M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -1.2% · vs SPY -3.4% · Latest Value $68.81M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q1 2025 13F filing, Altium Capital Management LLC disclosed 23 equity positions with a combined reported value of $39.48M. The filing implies a focused portfolio: its ten largest positions account for 88.3% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q1 2025 were ZVRA ($9.64M), ALNY ($6.75M), EOLS ($3.56M). By sector, the heaviest allocations are Health Care 84.5%, Materials 2.3%. Versus the prior quarter, allocation shifted toward Materials (+1.8pp), Other (+1.2pp) and away from Health Care (-3.0pp).
Versus the prior quarter, Altium Capital Management LLC opened 1 new positions, trimmed 3 and fully exited 0, a turnover rate of 20.0% of positions. The portfolio's overlap with the prior quarter was 26% of names.
The largest new positions opened in Q1 2025 were ALNY ($6.75M), INBS ($214.92K), STSS ($110.41K).
Of the 8 positions fully exited versus the prior quarter, the largest were ADMA ($23.92M), VERA ($18.27M), SRPT ($15.44M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q1 2025)
- ALNY ALNYLAM PHARMACEUTICALS INC · $6.75M
- INBS INTELLIGENT BIO SOLUTIONS IN · $214.92K
- STSS SHARPS TECHNOLOGY INC · $110.41K
- LGMK LOGICMARK INC · $106.83K
- SBFM SUNSHINE BIOPHARMA INC · $96.39K
Fully Exited (vs previous quarter)
- ADMA ADMA BIOLOGICS INC · prev qtr: $23.92M
- VERA VERA THERAPEUTICS INC · prev qtr: $18.27M
- SRPT SAREPTA THERAPEUTICS INC · prev qtr: $15.44M
- ESTA ESTABLISHMENT LABS HLDGS INC · prev qtr: $13.82M
- SRRK SCHOLAR ROCK HLDG CORP · prev qtr: $12.97M
- EW EDWARDS LIFESCIENCES CORP · prev qtr: $12.21M
- SLNO SOLENO THERAPEUTICS INC · prev qtr: $11.24M
- CAPR CAPRICOR THERAPEUTICS INC · prev qtr: $9.85M
Insider Transactions (Form 4)
Latest Altium Capital Management LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Altium Capital Management LLC is an SEC-registered 13F filer. As of Q2 2026 it reported 19 US equity positions with a combined value of $47.47M. HoldingsHub carries 11 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 19 positions · $47.47M reported value (Q2 2026)
- Top 10 holdings = 69.3% of reported value
- Largest position: RMT (ROYCE MICRO-CAP TR INC COM) at 8.6%
- Average position size: $2.50M
Sector Tilt
- Financials 91.6%
- Industrials 7.7%
- Health Care 0.7%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 6 added, 1 reduced
- 12 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
1.29M | $9.64M | 24.42% | Reduce | |
| 2 |
|
25.00K | $6.75M | 17.10% | New | |
| 3 |
|
296.19K | $3.56M | 9.03% | Reduce | |
| 4 |
|
7.25M | $3.41M | 8.63% | Reduce | |
| 5 |
|
419.13K | $3.28M | 8.31% | Reduce | |
| 6 |
|
303.86K | $2.12M | 5.37% | Reduce | |
| 7 |
|
360.59K | $2.10M | 5.32% | Reduce | |
| 8 |
|
1.05M | $1.66M | 4.20% | Reduce | |
| 9 |
|
904.87K | $1.44M | 3.64% | Reduce | |
| 10 |
|
177.42K | $897.73K | 2.27% | Reduce | |
| 11 |
|
303.95K | $881.45K | 2.23% | Reduce | |
| 12 |
|
1.05M | $714.94K | 1.81% | Reduce | |
| 13 |
|
168.59K | $613.66K | 1.55% | Reduce | |
| 14 |
|
273.20K | $587.39K | 1.49% | Reduce | |
| 15 |
|
574.25K | $399.39K | 1.01% | Reduce | |
| 16 |
|
123.26K | $324.16K | 0.82% | Reduce | |
| 17 |
|
9.40K | $315.37K | 0.80% | Hold | |
| 18 |
|
149.25K | $214.92K | 0.54% | New | |
| 19 |
|
49.33K | $184.50K | 0.47% | Reduce | |
| 20 |
|
4.04M | $110.41K | 0.28% | New | |
| 21 |
|
5.40M | $106.83K | 0.27% | New | |
| 22 |
|
50.47K | $96.39K | 0.24% | New | |
| 23 |
|
38.98K | $67.05K | 0.17% | Reduce | |
FAQ
What did Altium Capital Management LLC buy in 2025-Q1?
In its 2025-Q1 13F filing, Altium Capital Management LLC reported 23 equity positions worth $39.48M in aggregate; its largest disclosed positions were ZVRA ($9.64M), ALNY ($6.75M), EOLS ($3.56M).
How large is Altium Capital Management LLC's portfolio?
Altium Capital Management LLC reported $39.48M of long equity holdings across 23 positions as of 2025-Q1. Top-10 holdings account for 88.3% of reported value.
What is Altium Capital Management LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.